Encorafenib-d7 | CAS 2413673-15-9 - Request Quote
Encorafenib-d7
| SZ CAT No: | SZ-E056D02 |
| CAS No | 2413673-15-9 |
| Mol.F. | C22H20D7ClFN7O4S |
| Mol.Wt. | 547.1 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Encorafenib-d7 is chemically Methyl (S)-(1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-(propan-2-yl-d7)-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate. Encorafenib-d7 is supplied with detailed characterization data compliant with regulatory guideline. Encorafenib-d7 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Encorafenib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2413673-15-9
Purchase 2413673-15-9
Order 2413673-15-9
Enquire 2413673-15-9
price of 2413673-15-9
2413673-15-9 Supplier
2413673-15-9 Manufacturer
2413673-15-9 Exporter
buy high quality Encorafenib-d7
Purchase Encorafenib-d7
Encorafenib-d7 suppliers
Encorafenib-d7 manufacturers
Encorafenib-d7 price
Order Encorafenib-d7
Enquire Encorafenib-d7
Encorafenib-d7 cost
Encorafenib-d7 Supplier
Encorafenib-d7 Distributor
Encorafenib-d7 for Method Validation
Encorafenib Reference Standard
Encorafenib-d7 for ANDA Filing
Encorafenib-d7 for Forced Degradation Studies
Encorafenib-d7 Identification Standards
Encorafenib-d7 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


